DZ3149A1 - Composés dispersibles de macrolides et leur procédé de préparation. - Google Patents

Composés dispersibles de macrolides et leur procédé de préparation.

Info

Publication number
DZ3149A1
DZ3149A1 DZ003149A DZ003149A DZ3149A1 DZ 3149 A1 DZ3149 A1 DZ 3149A1 DZ 003149 A DZ003149 A DZ 003149A DZ 003149 A DZ003149 A DZ 003149A DZ 3149 A1 DZ3149 A1 DZ 3149A1
Authority
DZ
Algeria
Prior art keywords
agent
dispersible
preparation
sweetening agent
macrolide compounds
Prior art date
Application number
DZ003149A
Other languages
English (en)
French (fr)
Inventor
Noel Zakarian
Rene Gimet
Claude Laruelle
Dominique Toselli
Original Assignee
Cll Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma filed Critical Cll Pharma
Application granted granted Critical
Publication of DZ3149A1 publication Critical patent/DZ3149A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DZ003149A 1999-03-30 2000-03-30 Composés dispersibles de macrolides et leur procédé de préparation. DZ3149A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903978A FR2793690B1 (fr) 1999-03-30 1999-03-30 Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
PCT/FR2000/000800 WO2000057886A1 (fr) 1999-03-30 2000-03-30 Composes dispersibles de macrolides et leur procede de preparation

Publications (1)

Publication Number Publication Date
DZ3149A1 true DZ3149A1 (fr) 2001-08-16

Family

ID=9543821

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003149A DZ3149A1 (fr) 1999-03-30 2000-03-30 Composés dispersibles de macrolides et leur procédé de préparation.

Country Status (13)

Country Link
US (1) US6605301B2 (xx)
EP (2) EP1165094B1 (xx)
AT (1) ATE311890T1 (xx)
AU (1) AU3662700A (xx)
BR (1) BR0009447A (xx)
CA (1) CA2368880A1 (xx)
DE (1) DE60024601T2 (xx)
DZ (1) DZ3149A1 (xx)
ES (1) ES2254158T3 (xx)
FR (1) FR2793690B1 (xx)
MA (1) MA25526A1 (xx)
MX (1) MXPA01009845A (xx)
WO (1) WO2000057886A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
MXPA04005105A (es) * 2001-12-21 2004-08-19 Pfizer Prod Inc Formulaciones de acitromicina directamente compresibles.
PL372394A1 (en) 2002-02-01 2005-07-25 Pfizer Products Inc. Dry granulated formulations of azithromycin
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
WO2005044236A1 (en) * 2003-10-27 2005-05-19 Control Delivery Systems, Inc. Suspension delivery system for the sustained and controlled local release of pharmaceuticals
US20070015719A1 (en) * 2005-07-07 2007-01-18 Elan Pharma International Limited Nanoparticulate clarithromycin formulations
EP1906937B1 (en) * 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
CN100348190C (zh) * 2005-09-14 2007-11-14 北京正大绿洲医药科技有限公司 奥硝唑滴丸及其制备方法
EP2201939A1 (en) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Method for producing coated spiramycin and novel formulations containing the same
CN104825408A (zh) * 2012-12-31 2015-08-12 四川科伦药业股份有限公司 一种阿奇霉素分散片及其制备方法和用途
CN104739792B (zh) * 2015-04-17 2017-11-10 四川科伦药业股份有限公司 一种罗红霉素分散片制备方法
GR1008992B (el) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
CN108619105A (zh) * 2018-07-26 2018-10-09 江苏黄河药业股份有限公司 一种阿奇霉素分散片
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺
CN109528672B (zh) * 2019-01-30 2021-03-16 河北君临药业有限公司 一种乙酰螺旋霉素片及其制备方法
CN110548010A (zh) * 2019-04-02 2019-12-10 海南海神同洲制药有限公司 一种罗红霉素分散片制备方法
CN111388444B (zh) * 2020-03-18 2022-05-20 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法
CN114948887A (zh) * 2022-06-17 2022-08-30 中山可可康制药有限公司 一种克拉霉素分散片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106967A (en) * 1988-05-05 1992-04-21 The Procter & Gamble Company Functional sugar substitutes with reduced calories
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
FR2696346B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Nouvelles formulations pharmaceutiques de spiramycine.
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
FR2793690B1 (fr) 2003-01-03
ES2254158T3 (es) 2006-06-16
US20020061333A1 (en) 2002-05-23
DE60024601D1 (de) 2006-01-12
MXPA01009845A (es) 2003-02-12
EP1165094A1 (fr) 2002-01-02
EP1506780A3 (fr) 2005-03-02
DE60024601T2 (de) 2006-09-14
AU3662700A (en) 2000-10-16
BR0009447A (pt) 2002-01-08
ATE311890T1 (de) 2005-12-15
EP1165094B1 (fr) 2005-12-07
WO2000057886A1 (fr) 2000-10-05
CA2368880A1 (fr) 2000-10-05
MA25526A1 (fr) 2002-10-01
US6605301B2 (en) 2003-08-12
EP1506780A2 (fr) 2005-02-16
FR2793690A1 (fr) 2000-11-24

Similar Documents

Publication Publication Date Title
DZ3149A1 (fr) Composés dispersibles de macrolides et leur procédé de préparation.
Omura et al. Macrolides with gastrointestinal motor stimulating activity
DZ2945A1 (fr) Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.
EP0750907A3 (en) Stable macrolide and macrolide vaccine compositions
CA2387356A1 (en) Crystal form 0 and form i of clarithromycin and uses thereof
IL123571A0 (en) Process for aqueous granulation of clarithromycin
RO117501B1 (ro) Compoziţie farmaceutică cu eliberare controlată
DE69317877D1 (en) 4''-deoxyerythromycinderivate
CA2132429A1 (en) Alkylthio alkyl avermectins are active antiparasitic agents
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
MA26644A1 (fr) Derives de 1,7, diaza-spiro (3,5) nonane, procede de preparation et medicament les contenant
BRPI9811826B8 (pt) processos para a preparação de monossacarídeos
PL348242A1 (en) Macrolide lhrh antagonists
BG104827A (en) 3',3'-n-bis-substituted macrolide lhrh antagonists
AU4109393A (en) Avermectin difluoro derivatives
GR3024209T3 (en) Antiparasitic agents
NZ336756A (en) A process for the purification of roxithromycin by crystallisation from methanol
Baer et al. In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters
CA2403026A1 (en) Process for the preparation of 6-o-propargyl erythromycin derivatives
KR880002416B1 (ko) 3-(5'-리보헥산염)의 제조방법
RS50906B (sr) Primena specifične doze natrijum fondaparinuksa za lečenje acs
AU2712799A (en) The use of estradiol derivatives for treating side-effects during and/or after gnrha therapy
WO2004000864A3 (en) 11-c-substituted ketolides
MX9707399A (es) Composicion liberadora de halogeno para limpieza de excusados.
IT1301967B1 (it) Derivato di eritromicina ad attivita' antibiotica